STOCK TITAN

AbbVie to Present at the TD Cowen 44th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AbbVie (ABBV) to participate in the TD Cowen 44th Annual Health Care Conference on March 5, 2024. Key executives to present at 8:10 a.m. Central time. Live webcast and archived session available on AbbVie's Investor Relations website.
Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Feb. 27, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 8:10 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

AbbVie logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-td-cowen-44th-annual-health-care-conference-302071706.html

SOURCE AbbVie

FAQ

When will AbbVie participate in the TD Cowen 44th Annual Health Care Conference?

AbbVie will participate in the TD Cowen 44th Annual Health Care Conference on March 5, 2024.

Who are the key executives presenting at the conference for AbbVie?

The key executives presenting at the conference for AbbVie are Robert A. Michael, Scott T. Reents, Jeffrey R. Stewart, and Roopal Thakkar, M.D.

What time will the presentation by AbbVie take place at the conference?

The presentation by AbbVie will take place at 8:10 a.m. Central time.

Where can the live webcast of AbbVie's presentation be accessed?

The live webcast of AbbVie's presentation can be accessed through AbbVie's Investor Relations website at investors.abbvie.com.

Will an archived edition of AbbVie's session be available after the conference?

Yes, an archived edition of AbbVie's session will be available later on the same day.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

286.35B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.